Literature DB >> 10658973

Paired inhibitory and triggering NK cell receptors for HLA class I molecules.

M López-Botet1, T Bellón, M Llano, F Navarro, P García, M de Miguel.   

Abstract

Human natural killer (NK) cells specifically interact with major histocompatibility complex (MHC) class I molecules employing different receptor systems, shared with subsets of alphabeta and gammadelta T lymphocytes. Killer cell immunoglobulin-like receptors (KIRs) recognize groups of human leukocyte antigen (HLA) class Ia proteins displaying common structural features at the alpha-1 domain; among them, KIR2DL4 has been proposed to specifically interact with the class Ib molecule HLA-G1. Members of a related family of immunoglobulin (Ig)-like receptors (ILT2 or LIR-1 and ILT4 or LIR-2), expressed by other leukocyte lineages, interact with a broad spectrum of class Ia molecules and HLA-G1. On the other hand, CD94/NKG2-A(-C) and NKG2D lectin-like receptors, respectively, recognize the class Ib molecules HLA-E and MICA. A recurrent finding within the different receptor families is the existence of pairs of homologous molecules that often share the same ligands but display divergent functions. Inhibitory receptors tend to exhibit an affinity for HLA molecules higher than their activating counterparts. Recruitment of SH2 domain-bearing tyrosine phosphatases (SHP) by cytoplasmic phosphorylated immunoreceptor tyrosine-based inhibition motifs (ITIMs) is a crucial event for the inhibitory signalling pathway. By contrast, triggering receptors assemble with homodimers of immune tyrosine-based activation motif (ITAM)-bearing adaptor molecules (i.e., DAP12, CD3 xi) that engage tyrosine kinases (ZAP70 and syk).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10658973     DOI: 10.1016/s0198-8859(99)00161-5

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  24 in total

1.  Human CD8+ T cells specific for influenza A virus M1 display broad expression of maturation-associated phenotypic markers and chemokine receptors.

Authors:  Aki Hoji; Charles R Rinaldo
Journal:  Immunology       Date:  2005-06       Impact factor: 7.397

2.  MHC-I modulation due to changes in tumor cell metabolism regulates tumor sensitivity to CTL and NK cells.

Authors:  Elena Catalán; Seyma Charni; Paula Jaime; Juan Ignacio Aguiló; José Antonio Enríquez; Javier Naval; Julián Pardo; Martín Villalba; Alberto Anel
Journal:  Oncoimmunology       Date:  2015-02-03       Impact factor: 8.110

3.  IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism.

Authors:  Karl-Johan Malmberg; Victor Levitsky; Håkan Norell; Cristina Teixeira de Matos; Mattias Carlsten; Kjell Schedvins; Hodjattallah Rabbani; Alessandro Moretta; Kalle Söderström; Jelena Levitskaya; Rolf Kiessling
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

4.  Human NKG2E is expressed and forms an intracytoplasmic complex with CD94 and DAP12.

Authors:  Gerasim A Orbelyan; Fangming Tang; Benjamin Sally; Jason Solus; Bertrand Meresse; Cezary Ciszewski; Jean-Christophe Grenier; Luis B Barreiro; Lewis L Lanier; Bana Jabri
Journal:  J Immunol       Date:  2014-06-16       Impact factor: 5.422

5.  NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs.

Authors:  Vivien Béziat; Benjamin Descours; Christophe Parizot; Patrice Debré; Vincent Vieillard
Journal:  PLoS One       Date:  2010-08-06       Impact factor: 3.240

6.  Mouse TIGIT inhibits NK-cell cytotoxicity upon interaction with PVR.

Authors:  Noa Stanietsky; Tihana Lenac Rovis; Ariella Glasner; Einat Seidel; Pinchas Tsukerman; Rachel Yamin; Jonatan Enk; Stipan Jonjic; Ofer Mandelboim
Journal:  Eur J Immunol       Date:  2013-07-04       Impact factor: 5.532

Review 7.  Natural killer cell immunotherapy for cancer: a new hope.

Authors:  S Srivastava; A Lundqvist; R W Childs
Journal:  Cytotherapy       Date:  2008       Impact factor: 5.414

8.  Elevated frequency of gamma interferon-producing NK cells in healthy adults vaccinated against influenza virus.

Authors:  Brian R Long; Jakob Michaelsson; Christopher P Loo; Wassim M Ballan; Bien-Aimee N Vu; Frederick M Hecht; Lewis L Lanier; Joan M Chapman; Douglas F Nixon
Journal:  Clin Vaccine Immunol       Date:  2007-11-14

Review 9.  Biology and clinical impact of human natural killer cells.

Authors:  Sherif S Farag; Jeffrey B VanDeusen; Todd A Fehniger; Michael A Caligiuri
Journal:  Int J Hematol       Date:  2003-07       Impact factor: 2.490

10.  Blocking NK cell inhibitory self-recognition promotes antibody-dependent cellular cytotoxicity in a model of anti-lymphoma therapy.

Authors:  Liat Binyamin; R Katherine Alpaugh; Tracey L Hughes; Charles T Lutz; Kerry S Campbell; Louis M Weiner
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.